Jelena Spasić (Jelena Spasic)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Histone Deacetylase

Small Cell Lung Cancer

Immune Response

Dendritic Cells

Top Venues

Dose-response : a publication of International Hormesis Society

Expert review of anticancer therapy

Expert review of molecular diagnostics

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Vuletić, Katarina Mirjačić Martinović, Jelena Spasić
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer. Pharmaceutics 16 (1) (2023)
Ana Vuletić, Katarina Mirjačić Martinović, Jelena Spasić
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer. Pharmaceutics 16 (1) (2023)
Ana Vuletić, Katarina Mirjačić Martinović, Jelena Spasić
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer. Pharmaceutics 16 (1) (2023)
Jelena Spasić, Milena Čavić, Nemanja Stanic, Bojan Zaric, Tomi Kovacevic, Davorin Radosavljevic, Ljudmila Nagorni-Obradovic
Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose-response : a publication of International Hormesis Society 20 (2) (2022)
Vera Jokic, Katarina Savić Vujović, Jelena Spasić, Zoran Bukumiric, Mladen Marinkovic, Davorin Radosavljevic, Milena Čavić
Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma. Dose-response : a publication of International Hormesis Society 20 (3) (2022)
Vera Jokic, Katarina Savic-Vujovic, Jelena Spasić, Nemanja Stanic, Mladen Marinkovic, Davorin Radosavljevic, Milena Čavić
Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity. Expert review of anticancer therapy 21 (6) (2021)
Milena Čavić, Ana Krivokuca, Boljevic Ivana, Jelena Spasić, Milica Mihajlovic, Marijana Pavlovic, Ana Damjanovic, Davorin Radosavljevic, Radmila Jankovic
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals. Expert review of molecular diagnostics 21 (1) (2020)